Immunovant
$44.24
58
-$0.13-0.29% 11:47 Today
Statistics
Day High
44.42
Day Low
44.38
52W High
45.42
52W Low
14.47
Volume
30,076
Avg. Volume
-
Mkt Cap
9.16B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.75
-0.7
-0.64
-0.59
Expected EPS
-0.735138
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-505.61MNet Income
Analyst Ratings
45.43Average Price Target
The highest estimate is 62.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 71%
Hold 29%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IMVT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Argen X
ARGX
Mkt Cap65.05B
United Community Banks
UCB
Mkt Cap4.29B
Abbvie
ABBV
Mkt Cap468.22B
AMGEN
AMGN
Mkt Cap237.52B
GSK
GSK
Mkt Cap104.97B
Regeneron Pharmaceuticals
REGN
Mkt Cap85.87B
Novartis
NVS
Mkt Cap301.95B
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
About
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
Show more...
CEO
Eric Venker
Employees
315
Country
United States
ISIN
US45258J1025
Listings
0 Comments
Share your thoughts
FAQ
What is Immunovant stock price today?▼
The current price of IMVT is $44.24 USD — it has decreased by -0.29% in the past 24 hours. Watch Immunovant stock price performance more closely on the chart.
What is Immunovant stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Immunovant stocks are traded under the ticker IMVT.
Is Immunovant stock price growing?▼
IMVT stock has risen by +1.51% compared to the previous week, the month change is a +12.59% rise, over the last year Immunovant has showed a +191.14% increase.
What is Immunovant market cap?▼
Today Immunovant has the market capitalization of 9.16B
When is the next Immunovant earnings date?▼
Immunovant is going to release the next earnings report on November 18, 2026.
What were Immunovant earnings last quarter?▼
IMVT earnings for the last quarter are -0.75 USD per share, whereas the estimation was -0.63 USD resulting in a -19.26% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Immunovant revenue for the last year?▼
Immunovant revenue for the last year amounts to 0 USD.
What is Immunovant net income for the last year?▼
IMVT net income for the last year is -505.61M USD.
How many employees does Immunovant have?▼
As of August 24, 2026, the company has 315 employees.
In which sector is Immunovant located?▼
Immunovant operates in the Health & Wellness sector.
When did Immunovant complete a stock split?▼
Immunovant has not had any recent stock splits.
Where is Immunovant headquartered?▼
Immunovant is headquartered in DURHAM, United States.